Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes
Por:
Bertholet J, Anastasi G, Noble D, Bel A, van Leeuwen R, Roggen T, Duchateau M, Pilskog S, Garibaldi C, Tilly N, Garcia-Molla R, Bonaque J, Oelfke U, Aznar M, Ben Heijmen
Publicada:
1 dic 2020
Resumen:
Purpose: The POP-ART RT study aims to determine to what extent and how intrafractional real-time respiratory motion management (RRMM), and plan adaptation for interfractional anatomical changes (ART) are used in clinical practice and to understand barriers to implementation. Here we report on part II: ART using more than one plan per target per treatment course.
Materials and methods: A questionnaire on the current practice of ART, wishes for expansion or implementation, and barriers to implementation was distributed worldwide. Four types of ART were discriminated: daily online replanning, online plan library, protocolled offline replanning (all three based on a protocol), and ad-hoc offline replanning.
Results: The questionnaire was completed by 177 centres from 40 countries. ART was used by 61% of respondents (31% with protocol) for a median (range) of 3 (1-8) tumour sites. CBCT/MVCT was the main imaging modality except for online daily replanning (11 users) where 10 users used MR. Two thirds of respondents wished to implement ART for a new tumour site; 40% of these had plans to do it in the next 2 years. Human/material resources and technical limitations were the main barriers to further use and implementation.
Conclusions: ART was used for a broad range of tumour sites, mainly with ad-hoc offline replanning and for a median of 3 tumour sites. There was a large interest in implementing ART for more tumour sites, mainly limited by human/material resources and technical limitations. Daily online replanning was primarily performed on MR-linacs. (C) 2020 The Authors. Published by Elsevier B.V.
Filiaciones:
Bertholet J:
Inst Canc Res, Joint Dept Phys, London, England
Royal Marsden NHS Fdn Trust, London, England
Univ Bern, Bern Univ Hosp, Inselspital, Dept Radiat Oncol,Div Med Radiat Phys, CH-3010 Bern, Switzerland
Anastasi G:
Royal Surrey Cty Hosp, Dept Med Phys, St Lukes Canc Ctr, Guildford, Surrey, England
Noble D:
Univ Cambridge, Canc Res UK VoxTox Res Grp, Addenbrookes Hosp, Cambridge Biomed Campus, Cambridge, England
Bel A:
Amsterdam UMC, Dept Radiat Oncol, Nijmegen, Netherlands
van Leeuwen R:
Radboud Univ Nijmegen Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
Roggen T:
Varian Med Syst Imaging Lab GmbH, Appl Res, Dattwil, Switzerland
Duchateau M:
MIM Software Inc, Cleveland, OH USA
Pilskog S:
Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway
Univ Bergen, Dept Phys & Technol, Bergen, Norway
Garibaldi C:
European Inst Oncol IRCCS, Unit Radiat Res, IEO, Milan, Italy
Tilly N:
Elekta Instruments AB, Stockholm, Sweden
Uppsala Univ, Dept Immunol Genet & Pathol, Med Radiat Phys, Uppsala, Sweden
Garcia-Molla R:
Consorcio Hosp Gen Univ Valencia, Serv Radiofis & Protecc Radiol, Valencia, Spain
Bonaque J:
Consorcio Hosp Prov Castellon, Serv Radiofis & Protecc Radiol, Castellon De La Plana, Spain
Oelfke U:
Inst Canc Res, Joint Dept Phys, London, England
Royal Marsden NHS Fdn Trust, London, England
Aznar M:
Univ Manchester, Div Canc Sci, Fac Biol Med & Hlth, Christie NHS Fdn Trust, Manchester, Lancs, England
Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
Ben Heijmen:
Erasmus MC Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands
|